double-skinned crabsVietnamese crab exporter
Advertisement
Advertisement
WuXi AppTec
TOPIC
 / company

WuXi AppTec

WuXi AppTec
WuXi AppTec
WuXi AppTec is Asia's largest provider of contract pharmaceutical research, helping drug makers shorten their discovery and development procedures. Its platform is used by more than 6,000 customers, including biotech and pharmaceutical companies, research institutions, researchers, scientists and entrepreneurs in more than 30 countries. The company was founded by Ge Li, who also chairs WuXi Biologics.
Chairman / President
Li Ge
CEO / Managing Director
Chen Minzhang
CFO / Finance Director
Shi Ming
Industry
Biopharmaceutical
Website
wuxiapptec.com
Headquarters address
288 Fute Zhong Road Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, China
Stock Code
SEHK:603259
SSE:603259
Year founded
2000
LATEST China Science NEWS

China tests a Dune-like iron-harvesting crawler robot in the Taklamakan Desert

videocam
Chinese scientists have extracted iron from the sands of the country’s largest desert using a magnetic separator. Photo: Handout

Chinese team finds 11,700 new viruses in world’s biggest seabed metal deposit

videocam
The viruses in the Clarion-Clipperton zone are likely to have unique characteristics that reflect the unusual environment in which they have evolved, which is rich in heavy metals while being extremely deficient in available nutrients. Photo: Handout

China is working on a submarine tank that can operate underwater for 2 hours

7
Researchers from the Inner Mongolia First Machinery Group and the Beijing Institute of Technology are looking at how Chinese military equipment can rapidly transform to meet changing wartime demands. Photo: Shutterstock

China-US astronomy team may have found possible relic of a recent ‘gold factory’

videocam
The five-telescope HESS array in Namibia. Photo: Klepser/Wikimedia Commons

New Energy | China bets on molten salt and CO2 to help meet power needs

China bets on molten salt and CO2 to help meet its power needs
MORE China Science NEWS
Chinese biopharma’s global expansion
China technology

Chinese biopharma’s global expansion

Chinese developers of innovative drugs are tying up with industry giants to accelerate overseas growth, raise funds and share risks.

China’s private sector

China needs monkeys: lab animal shortage could hinder biotech growth

Semiconductors

CXMT vs Pentagon: how China’s tech firms are challenging US blacklists in court

Hong Kong

China’s pharma contractors rally on pushback to US supply chain pressure

Genscript posted adjusted net profit of US$62.52 million for the six months ended June 30, a 203 per cent year-on-year surge.

Greater collaboration between Chinese biotech firms and multinational giants is expected to support growth this year. Photo: Shutterstock
US-China relations

Chinese drone maker DJI gets another shot at Pentagon blacklist removal

Latest ruling gives Shenzhen-based company hope after years-long legal battle with the US Department of Defence.

videocam
US-China relations

US judge blocks Pentagon’s ‘Chinese military’ label for WuXi AppTec

Court finds defence officials misread evidence involving a state-linked fund, Chinese universities and a PLA hospital.

videocam
12
Advertisement
Advertisement
Advertisement
Banking & finance

China biotech giant WuXi AppTec sees first-half earnings surge amid US scrutiny

Strong orders for weight-loss and diabetes treatments drive firm’s growth, despite being caught up in US efforts to curb China’s ambitions.

Wuxi AppTec, Asia’s largest provider of contract pharmaceutical research, surpassed analysts’ expectations in the first half of the year. Photo: Handout
US-China trade war

Record Chinese biotech out-licensing meets rising US scrutiny

Surging cross-border deals out of China are running headlong into intensifying US national security fears.

videocam
22
Banking & finance

As weight-loss drug orders surge, global funds pile into China’s WuXi AppTec

Pharmaceutical contractor’s GLP-1 programmes and surging stock gains have made it a magnet for global investors.

China manufacturing

The next rare earths? Why US fears another Chinese manufacturing advantage

China’s production of drug inputs has boomed in recent years, increasing market share and prompting fears of weaponisation in Washington.

videocam
26
Illustration: Victor Sanjinez
US-China relations

Senate bill seeks to curb US reliance on China in drug industry

Lawmakers want more transparency around foreign influence in the sector, saying there’s no reason to allow rival to control supply chain.

There are growing concerns over American dependence on China for drug ingredients and medical supply chains. Photo: Getty Images
Hong Kong stock market

Hong Kong stocks rebound from choppy trading triggered by turmoil in US

Hang Seng Index bounces back after overnight plunge in Nasdaq-100 on concerns about frothy tech valuations.

5
US-China relations

Pentagon sued by Alibaba over ‘arbitrary’ military blacklist targeting Chinese firms

Technology giant says US defence department wrongly labelled it a Chinese military company without evidence.

videocam
12
China’s private sector

Bigger, fewer, tougher: the new era of China-US biotech partnerships

China’s biotech boom continues to attract Western drug makers even as Washington expands investment and technology controls.

In focus: Chinese biotech firms such as Jiangsu Hengrui Pharmaceutical are navigating growing geopolitical scrutiny as cross-border licensing deals continue to expand. Photo: Shutterstoc
US-China relations

China accuses US of power abuse with expanded blacklist of Chinese firms

Washington is using national security as a cover for its efforts to contain Chinese companies doing business overseas, Beijing says.

videocam
12
The Pentagon is using national security as a pretext to curb the development of Chinese firms, China says. Photo: Reuters
US-China relations

Biotech firm WuXi sues US over allegations it supports China’s military

The company says it suffered substantial reputational and operational harm after being placed on a Pentagon blacklist.

videocam
China’s private sector

China biotech firms say global push is ‘irreversible’ despite US barriers

Chinese drug makers are increasingly relying on overseas licensing deals to reach global markets amid growing geopolitical tensions.

Advertisement
Advertisement
Advertisement
US-China relations

How will the Pentagon’s expanded blacklist of Chinese firms affect Xi’s US visit?

Washington’s latest move tests fragile ‘stability’ reached at leadership summit in Beijing and highlights intense competition, analysts say.

videocam
27
Chinese robotics company Unitree, whose G1 Humanoid Robot was displayed during London Tech Week on Monday, has been added to the Pentagon's updated list of Chinese military-linked companies. Photo: Reuters
China’s private sector

Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts

Growing collaboration between multinational drug makers and Chinese companies not expected to slow after US move.

US-China tech war

Pentagon blacklist raises spectre of investment curbs for Chinese tech firms

Chinese tech giants including Alibaba and Baidu strongly reject the Pentagon’s characterisation of them as “Chinese military companies”.

8
US-China relations

Pentagon blacklists China tech giants as US competition expands

Alibaba, Baidu, BYD and Unitree were among Chinese companies added to a US military blacklist as competition between the nations expands further into technology.

Photo: Xinhua
Hong Kong stock market

Alibaba and WuXi AppTec decline in Hong Kong after addition to US blacklist

Designation of Chinese firms fuels investor unease, with markets bracing for a potential Fed tightening and an unwinding of the AI trade.

The Hang Seng Index fell 0.4 per cent on Tuesday. Photo: Jelly Tse
US-China relations

US adds Alibaba, BYD, other Chinese tech champions to military company blacklist

Trump administration has designated top China firms as ‘Chinese military companies’ operating in the United States.

videocam
64
Banking & finance

China sees revival of foreign investors through IPOs, convertibles: UBS

The trend is part of a broader recovery of interest in Chinese assets from investors overseas.

videocam
Hong Kong company reporting season

WuXi AppTec shares surge 14% in Hong Kong after record first-quarter earnings

The Chinese company’s revenue rose nearly 29 per cent to 12.44 billion yuan, while profit surged about 27 per cent to 4.65 billion yuan.

WuXi AppTec’s R&D centre in Shanghai. Photo: CFOTO/Future Publishing via Getty Images
China’s private sector

WuXi AppTec posts record first-quarter revenue on strong global demand

Earnings top estimates as multinational pharmaceutical firms ramp up investment and partnerships in China.

WuXi AppTec’s first quarter results marked the third consecutive quarter in which revenue remained above the 12 billion yuan mark. Photo: Shutterstock
China’s private sector

US reshoring drive casts shadow over China’s contract drug makers, analyst says

Strong order backlogs underpin earnings through 2027, but analysts warn longer-term demand is less certain as US firms reshore production.

China’s private sector

Lab monkey price tag climbs to US$20,000 thanks to China’s biotech boom

The cost of a single monkey exceeds the average annual salary in China and approaches a pandemic-era spike amid growth in drug licensing deals.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement